Current Medicinal Chemistry

Reactive Oxygen Species in Cancer Biology and Anticancer Therapy
pp. 3677-3692(16)
Authors: Yang, Y.; Karakhanova, S.; Werner, J.; V. Bazhin, A.

Heterocyclic HIV-Protease Inhibitors
pp. 3693-3710(18)
Authors: Calugi, C.; Guarna, A.; Trabocchi, A.

A Focus on Heme Oxygenase-1 (HO-1) Inhibitors
pp. 3711-3732(22)
Authors: PittalÃ, V.; Salerno, L.; Romeo, G.; N. Modica, M.; A. Siracusa, M.

A Novel Promising Therapeutic Option Against Hepatitis C Virus: An Oral Nucleotide NS5B Polymerase Inhibitor Sofosbuvir
pp. 3733-3742(10)
Authors: Gentile, I.; Borgia, F.; R. Buonomo, A.; Castaldo, G.; Borgia, G.

Sulfur-based Mechanistic Probes for Enzyme-catalyzed Reactions
pp. 3743-3758(16)
Author: Zheng, Weiping

The Renaissance of Polymyxins
pp. 3759-3773(15)
Authors: Kadar, B.; Kocsis, B.; Nagy, K.; Szabo, D.

Gene Therapy, A Targeted Treatment for Diabetic Nephropathy
pp. 3774-3784(11)
Authors: Lin, X.; Tao, L.; Tang, D.

Tuberculosis Clinical Trial Update and the Current Anti-Tuberculosis Drug Portfolio
pp. 3785-3796(12)
Authors: Carlos Palomino, Juan; Martin, Anandi

Carbasugar Probes to Explore the Enzyme Binding Pocket at the Anomeric Position: Application to the Design of Golgi Mannosidase II Inhibitors
pp. 3797-3801(5)
Authors: V. Vinader, M.; Afarinkia, K.